Connor, Clark & Lunn Investment Management Ltd. Insmed Inc Transaction History

Connor, Clark & Lunn Investment Management Ltd.

$28.9 Billion
Q3 2025

A detailed history of Connor, Clark & Lunn Investment Management Ltd. transactions in Insmed Inc stock. As of the latest transaction made, Connor, Clark & Lunn Investment Management Ltd. holds 51,658 shares of INSM stock, worth $9.98 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

51,658

Previous 226,142 77.16%

Holding current value

$9.98 Million

Previous $22.8 Million 67.31%

% of portfolio

0.03%

Previous 0.09%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 13, 2025	SELL	$96.14 - $147.2 $16.8 Million - $25.7 Million	-174,484 Reduced 77.16%	51,658 $7.44 Million
Q2 2025 Aug 07, 2025	BUY	$64.81 - $105.9 $13.7 Million - $22.3 Million	210,999 Added 1393.38%	226,142 $22.8 Million
Q1 2025 May 12, 2025	BUY	$65.25 - $83.83 $988,080 - $1.27 Million	15,143 New	15,143 $1.16 Million
Q2 2024 Aug 09, 2024	SELL	$22.0 - $69.71 $883,850 - $2.8 Million	-40,175 Reduced 48.94%	41,908 $2.81 Million
Q1 2024 May 09, 2024	SELL	$25.72 - $29.94 $4.87 Million - $5.67 Million	-189,229 Reduced 69.75%	82,083 $2.23 Million

Q4 2023 Feb 09, 2024	SELL	$23.42 - $31.74 $4.09 Million - $5.55 Million	-174,792 Reduced 39.18%	271,312 $8.41 Million
Q3 2023 Nov 13, 2023	SELL	$19.86 - $26.93 $781,590 - $1.06 Million	-39,355 Reduced 8.11%	446,104 $11.3 Million
Q2 2023 Aug 10, 2023	SELL	$16.44 - $21.1 $508,242 - $652,306	-30,915 Reduced 5.99%	485,459 $10.2 Million
Q1 2023 May 09, 2023	SELL	$16.26 - $21.73 $161,055 - $215,235	-9,905 Reduced 1.88%	516,374 $8.8 Million
Q4 2022 Feb 10, 2023	BUY	$16.98 - $23.15 $5.49 Million - $7.49 Million	323,503 Added 159.54%	526,279 $10.5 Million
Q3 2022 Nov 10, 2022	BUY	$20.88 - $28.21 $3.23 Million - $4.36 Million	154,711 Added 321.88%	202,776 $4.37 Million
Q2 2022 Aug 05, 2022	BUY	$17.07 - $25.71 $600,949 - $905,120	35,205 Added 273.76%	48,065 $948,000
Q1 2022 May 12, 2022	BUY	$20.42 - $28.13 $262,601 - $361,751	12,860 New	12,860 $302,000

Others Institutions Holding INSM

# of Institutions

644

Shares Held

208M

Call Options Held

3.83M

Put Options Held

4.26M

View Full List

About INSMED Inc

Ticker INSM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 135,476,992
Market Cap $26.2B
Description
Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...

More about INSM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Connor, Clark & Lunn Investment Management Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Connor, Clark & Lunn Investment Management Ltd. with notifications on news.

Account

Connor, Clark & Lunn Investment Management Ltd. Insmed Inc Transaction History